ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,374Medicare Part D Prescriptions Filled, Including Refills

Rank: 152 out of 1171

$543K Total Retail Price of All Prescriptions

Rank: 188 out of 1171

565 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,873 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 391 382 1 2
FUROSEMIDE 376 365 2 6
OMEPRAZOLE 367 360 3 5
LISINOPRIL 326 299 4 3
LEVOTHYROXINE SODIUM 320 320 5 4
LOSARTAN POTASSIUM 282 266 6 14
SIMVASTATIN 277 275 7 1
ATORVASTATIN CALCIUM 273 260 8 10
METOPROLOL TARTRATE 241 231 9 11
METFORMIN HCL 223 200 10 7
HYDROCODONE-ACETAMINOPHEN 189 171 S3 11 8
PRAVASTATIN SODIUM 186 177 12 13
POTASSIUM CHLORIDE 184 174 13 19
FAMOTIDINE 178 172 14 75
DONEPEZIL HCL 169 169 15 24
CARVEDILOL 149 132 16 20
ALLOPURINOL 147 143 17 31
WARFARIN SODIUM 129 122 18 12
PREDNISONE 126 107 19 39
TRIAMTERENE-HCTZ 120 120 20 58
CRESTOR 119 119 21 27
GABAPENTIN 112 99 22 16
HYDROCHLOROTHIAZIDE 110 106 23 9
FENOFIBRATE 106 105 24 81
NAMENDA 102 102 25 42
GLIMEPIRIDE 94 88 26 34
SPIRONOLACTONE 91 85 27 53
DOXAZOSIN MESYLATE 90 90 28 82
HYDRALAZINE HCL 89 84 29 60
CITALOPRAM HBR 89 89 29 22
FINASTERIDE 81 80 31 88
SERTRALINE HCL 79 76 32 23
CLONIDINE HCL 79 78 32 45
FLUTICASONE PROPIONATE 78 66 34 30
SYNTHROID 78 70 34 48
METOPROLOL SUCCINATE 76 76 36 17
DILTIAZEM 24HR CD 72 72 37 101
BYSTOLIC 70 70 38 96
ALENDRONATE SODIUM 66 66 39 33
TRAMADOL HCL 64 64 40 18
VERAPAMIL ER 64 64 40 91
ROPINIROLE HCL 62 62 42 119
DILTIAZEM 24HR ER 61 58 43 112
KLOR-CON 10 60 60 44 126
KLOR-CON M20 60 60 44 41
LIPITOR 59 59 46 92
ATENOLOL 58 58 47 15
AZITHROMYCIN 56 50 48 43
DILTIAZEM ER 52 52 49 221
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 51 49 26
ENALAPRIL MALEATE 51 39 51 73
ZETIA 51 51 51 63
TRAZODONE HCL 50 50 53 37
ISOSORBIDE MONONITRATE ER 50 50 53 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.